The predominance of pathogenic gating variants is in contrast to other potassium channel disease genes, such as KCNH2; 88% of 193 studied KCNH2 loss-of-function variants disrupt cell surface expression [50]. The gene discussed is KCNA3; the disease is glycogen storage disease VI.